My Profile   |   Print Page   |   Contact Us   |   Sign In   |   Register
ASAP Blog
Blog Home All Blogs
Welcome to ASAP Blog, the best place to stay current regarding upcoming events, member companies, the latest trends, and leaders in the industry. Blogs are posted at least once a week; members may subscribe to receive notifications when new blogs are posted by clicking the "Subscribe" link above.

 

Search all posts for:   

 

Top tags: alliance management  alliances  collaboration  partnering  alliance  partners  alliance managers  partner  alliance manager  ecosystem  partnerships  The Rhythm of Business  partnership  Jan Twombly  biopharma  governance  Eli Lilly and Company  Strategic Alliance Magazine  Vantage Partners  IBM  IoT  strategy  ASAP BioPharma Conference  healthcare  NetApp  2015 ASAP Global Alliance Summit  Cisco  cloud  communication  innovation 

Making Adjustments: ASAP Global Alliance Summit Now in June!

Posted By Michael Leonetti, CSAP, Monday, March 9, 2020

We’ve all had the experience of an unexpected event that suddenly threw a wrench into our alliances or our lives. Depending on the nature of the event, its magnitude, and how close to home it hits, we generally do our best to understand how the landscape has changed, adjust to the implications, make accommodations, and move forward. Reality may defy our hopes and expectations, but we pick up the pieces, dust ourselves off, and keep getting up in the morning amid the now-altered environment.

So it is with the coronavirus, or COVID-19, whose effects worldwide have already proven serious. Our hearts go out to all those who have been directly affected by this virus, especially the families of those who have died from it around the globe. In addition, this contagious disease—and the fear of it—has already had a significant economic impact, including declines in business and vacation travel and the cancellation or postponement of a number of conventions, conferences, and trade shows in various industries. Most organizations have been forced to respond in some way, whether to shift events to alternative dates or from physical to virtual, to curtail travel to safeguard their people, or to try to limit the damage to their bottom line. Or all of the above.

We at ASAP have faced these challenges as well, resulting in the difficult decision to reschedule our Global Alliance Summit, which had been scheduled for next week, to June 23–25 in Tampa, Florida. In the great scheme of things this move may barely register, but for a member organization like ours, as you can imagine, it’s a big deal. Shifting the Summit to new dates has required a huge and immediate lift on the part of ASAP staff and board, which is ongoing as I write this.

The good news is, the show will go on! I’m very happy that we were able to secure the original conference venue, the Renaissance Tampa International Plaza Hotel, for our late-June dates. I’m even more pleased to report that at present, nearly 75 percent of our presenters, panelists, and moderators have confirmed that they’ll be there.

What this means is that we’ll still have a terrific program, as planned—a program that, as always, includes presentations by some of the alliance and partnering profession’s best and brightest minds and leading lights, including these:

  • A keynote presentation by Steve Steinhilber, global vice president, ecosystems and business development, at Equinix: “Creating Alliances and Digital Ecosystem Capabilities in an Increasingly Platform Enabled and Interconnected World.” Steve ran alliances at Cisco for a number of years, and while there authored the influential book Strategic Alliances: Three Ways to Make Them Work (2008). He was also among those interviewed for our Q1 2020 cover story in Strategic Alliance Quarterly on the rise and far-reaching effects of ecosystems in nearly every industry, and his insights into this important and growing area are sure to be valuable and applicable to any industry.
  • A fascinating panel moderated by Adam Kornetsky of Vantage Partners titled “Big Pharma M&A and Alliance Portfolios: What’s at the End of the Rainbow?” This interactive discussion will feature panelists including Mark Coflin, CSAP, vice president and head of global alliances at Takeda Pharmaceuticals; Dana Hughes, vice president of integration management and alliance management at Pfizer; and Jeffrey C. Hurley, senior director, GBD global alliance lead at Takeda. These longtime ASAP members will share their recent M&A experiences, provide insights into how alliance portfolios have been managed through the transaction process, and engage participants in sharing additional perspectives critical for unlocking and maximizing the full value of an alliance portfolio.
  • A presentation by Dan Rippey, director of engineering for Microsoft’s One Commercial Partner program, and Amit Sinha, chief customer officer and cofounder of WorkSpan, called “How the Microsoft Partner-to-Partner Program Is Disrupting the Way Technology Companies Are Leveraging the Power of Ecosystems for Business Growth, Customer Acquisition, and Gaining a Competitive Advantage.” With the rise of ecosystems has come the increasing deployment of partner-to-partner (P2P) programs, and Microsoft’s may be the largest on the planet, connecting partners directly with each other to deliver value to customers without Microsoft’s intervention. Powered by WorkSpan Ecosystem Cloud, this program increases profitability by selling solutions from one or more of Microsoft’s partners, achieving faster time-to-market by leveraging prebuilt joint solutions, closing larger deals, and reaching more customers by co-selling with other Microsoft partners for a bigger joint pipeline. This new model of partnering has wide applicability and Dan and Amit’s description of how it works is a must-hear.
  • Another terrific panel moderated by Jan Twombly, president of The Rhythm of Business, called “Biopharma Commercial Alliance Management Challenges.” Panelists will include Brooke Paige, CSAP, ASAP board chair and former vice president of alliance management at Pear Therapeutics; and David S. Thompson, CSAP, chief alliance officer at Eli Lilly and Company. In the long life of a successful biopharma alliance, the commercialization phase brings its own particular challenges and problems. This panel promises to be a lively discussion of such topics as how alliance managers deliver value in a commercial alliance, considerations for driving alignment in local geographies and at a corporate level, aspects of alliance governance to get right to maximize value, and much more.

I’m not indulging in hyperbole when I say that these are just a very few of the highlights. Again,  more than three-quarters of the original Summit agenda is planned  to remain intact—including preconference workshops, single-speaker presentations, illuminating panel discussions, and of course, valuable networking opportunities.

We know there are many factors governing decisions on where to travel and why—especially under current conditions. But we’re confident that even after shifting to the June dates, we’ll be fielding a stellar lineup at the Summit in Tampa—one you’ll want to be present for. If you haven’t registered yet and/or for whatever reason were uncertain about attending in March, you now have some extra time to decide.

Additionally, the Renaissance has set up a new block of rooms at our discounted rate of $219.00+ per night. To book your room for the new conference dates, please click on the link below:

https://www.marriott.com/event-reservations/reservation-link.mi?id=1583953400577&key=GRP&app=resvlink

Let’s all try to plan for normal again! Won’t you join us? I hope to see you in Tampa!

Tags:  alliances  Amit Sinha  biopharma  Brooke Paige  Dan Rippey  Dana Hughes  David Thompson  Ecosystems  Eli Lilly and Company  Equinix  Jan Twombly  Jeffrey Hurley  Mark Coflin  Microsoft  P2P  partners  Pfizer  Steve Steinhilber  Takeda  The Rhythm of Business  Vantage Partners  WorkSpan 

Share |
PermalinkComments (0)
 

Academia and Industry—Creating a Seamless Fit (Part Two)

Posted By Genevieve Fraser, Wednesday, June 7, 2017

In the session “Making the Most of Industry-Academia Collaborations,” Mark Coflin, CSAP, head of alliance management at Shire Pharmaceuticals was joined by his colleague, Joe Sypek, PhD, director and external science lead at Shire, as they explored cultural differences between partners in academia and industry working together to find a cure for a disease (see Part I of this blog post) http://www.strategic-alliances.org/blogpost/1143942/277595/Academia-and-Industry-Partnerships-Creating-a-Seamless-Fit--Part-I. Joining them at the 2017 ASAP Global Alliance Summit, “Profit, Innovation, and Value for the Part­nering Enterprise,” were Sanford Burnham Prebys Medical Discovery Institute’s (SBP’s) Paula Norris, PhD, laboratory director and project manager, and Sarah Hudson, PhD, R&D project and operations associate director. The 2017 Summit was held Feb. 28-March 2 in San Diego, Calif.

 

Norris works with principal investigators (PIs) to develop strategic plans for lab operations and policies. On any given project, she might work with four or five partners at a time. Some are smaller start-up companies; others are larger pharmaceutical companies. “In the past, we were grant-centric, but now less so as we work with industries,” she explained. “We explore a partner’s expectations, then go back to our group and discuss what we need to do to make it work. But there’s a language gap with industry. The language in industry is not necessarily the same as ours. So at times, there’s miscommunication. But we’ve gotten better at asking questions about what they mean, especially when we’re not sure [of] what they want or their end goal.”

 

“We’ve spent time working on culture and skill seton education across the institute. For example, what is a hit or lead?” she asked rhetorically. “We need to educate in terms of the basic terms of an alliance partner’s language.”

 

“It’s also important to hone in on expectations. If partners have different expectations, it can cause problems,” Norris stated. “Instead of going off on a tangent, we need to understand the scope and what the goals are and stay focused. Otherwise, we will fail to line up with the milestones. The criteria are only met when the milestone is achieved. “

 

“It can be a challenge if a partner says it’s a ‘no go,’ and we think there is an avenue. We need to remember that the money comes from a partner. If there’s scope creep, we need to draw them back to achieve the milestone. To do that you must have the right people involved and have communicated broadly. You need to define the statement of workmake sure the language is conciseso both parties are clear about what they need to do for the project.”

 

Hudson acknowledged that she and Norris are proud of the innovation and knowledge base of PIs, but to retain the culture, academia must adapt to make industry-academia projects run more smoothly. This only happens if someone is designated as the point person: “It’s quite important for long-term capabilities. A manager makes sure deadlines are met for milestones.”

As the leader of the project manager group at SBP, Hudson’s role is to partner with scientific project leaders in collaborations and initiatives. “These pharmaceutical and biotech companies, as well as alliances with other academic institutions, all have the same flavor but run differently,” Hudson conceded. “So, we do what we must to adapt with projects run by a joint steering committee.”

It’s important not to assume everything is going well, Coflin added.  As in every kind of relationship, the person talking needs to be truthful so that members of the team come to you with issues.  Being a good partner involves communicationsmonthly meetings. “Scientists tend to be reserved so they won’t get scooped. You need to create trust. Labs operate in a silo working by themselves, but to have an effective partnership, you need to work in a collaborative environment,” he said.

 

Scientists need to develop basic alliance management skills, Hudson stressed. “Because we don’t have large infrastructure, it’s important that we impart these skills to scientists so we can be proactive, instead of merely responsive.”

 

Since their groups have been working on alliance skills, both Hudson and Norris have personally seen a difference in greater productivity and efficiency through collaboration as their projects progress.

 

Sypek agrees that things break down when there is a lack of communication. If you are to reach the next level, you need to feel comfortable about talking with partners, he said. “The more you communicate, the better you get. But each project must be treated as individual, as unique, especially if the PI and/or goals are different.”

 

“What you are doing is transformative to an institution, Coflin stated. “Just as we do at Shire, you must prepare your institution to partner. Despite the fact they might be uncomfortable, it’s important to give them tools to be ready to partner. That sort of preparation is how you build capability.”

 

The entire panel then agreed on one axiom: A common goal helps make it work!

Part I of this blog post focuses on Shire Pharmaceutical’s perspective on academic-industry partnerships. http://www.strategic-alliances.org/blogpost/1143942/277595/Academia-and-Industry-Partnerships-Creating-a-Seamless-Fit--Part-I

Tags:  alliance partners  alliance skills  biotech  collaboration  communication  Joe Sypek  Mark Coflin  partner  partner language  partners  Paula Norris  principal investigators  Sanford Burnham Prebys Medical Discovery Institute  Sarah Hudson  Shire Pharmaceuticals  transformation 

Share |
PermalinkComments (0)
 

ASAP New England Chapter Holds Well-Attended, Practical Meeting on Alliance Management Skills and Competencies

Posted By Cynthia B. Hanson, Tuesday, February 21, 2017
Updated: Monday, February 20, 2017

Neither snowstorm, nor sleet, nor freezing temps can keep Jeffrey Shuman, PhD, CSAP, principal at The Rhythm of Business, from a New England ASAP Chapter meeting. And apparently, it couldn’t keep four other panelists and about 40 attendees from the discussion on “Alliance Management as a ProfessionSkills, Competencies,” at the Charles River Accelerator and Development Lab in Cambridge, Mass., on Jan. 31.  

The panel talked about the basic alliance management foundational skills recognized by recruiters, career paths, adapting to the evolving ecosystem, soft skills that are key to performing the job, and other related topics in a dynamic, one-hour meeting. In addition to Shuman, who moderated the discussion and is also professor of management at Bentley University, the panel members included ASAP’s own President and CEO Michael Leonetti, CSAP; Marc Silber, founder and president of Crossover Consulting Group, a life sciences headhunting and recruiting agency; Mark Coflin, CSAP, head of alliance management, corporate planning & program management, Shire; Michelle Gardner, business development executive, cloud service providers, at IBM, who arranged the practical meeting.

The complexity of multi-industry, multi-partner alliances with a global reach has made alliance management training skills increasingly important. “Not everybody needs to be an alliance manager, but it’s our view that everybody increasingly needs to have some alliance management skills because alliance capability needs to extend to the perimeter, to the edge of the organization,” Shuman says. For example, scientists increasingly are working with other scientists in other organizations on tech solutions or drugs, whereas previously, most of the innovation was done internally. “What we see happening is folks in those areas are coming to their alliance folks and asking for advice,” he explains. “More people are interacting in these collaborations, and they really need some understanding of the skills and toolset.”

“Given that the speed, scale, and scope of partnering has increased, companies can’t afford to build an alliance management group that can manage all of the different parts of their business. When partnering with external entities, many people need a better understanding of the skills and tools.”

Among the topics that surfaced from the discussion were:

  • How to progress to an alliance management role from another area of the company
  •  Areas alliance managers are recruited from
  •  The various career paths and roles alliance managers can move into
  • Ecosystems, multi-party networks, hub-and-spoke models, and two-party relationships
  • The differences between being an alliance manager in biopharma/pharma and high tech

The topics likely will resurface in various sessions at the 2017 ASAP Global Alliance Summit, “Profit, Innovation, and Value for the Part­nering Enterprise,” held Feb. 28-March 2 at the San Diego Marriott Mission Valley, San Diego, California. Some of these topics also appear in a newly released ebook “The Power To Partner Everywhere: Why You Need It, What It Is, How To Build It,” by The Rhythm of Business Principals Jan Twombly, CSAP, Shuman, and Lorin Coles, CSAP, co-founder and CEO of Alliancesphere, LLC. Their two companies joined forces to form the SMART Partnering Alliance.  For a copy of the ebook, go to http://rhythmofbusiness.com/.

Tags:  alliance management  alliance manager  biopharma  career path  ecosystem  high tech  Innovation  Jeff Shuman  Marc Silber  Mark Coflin  Michelle Gardner  multi-industry  multi-partner alliances  partnering  Partnering Enterprise  pharma  Profit  SMART Partnering Alliance  The Rhythm of Business  tools  training skills 

Share |
PermalinkComments (0)
 

The Final Handshake: What’s an Alliance Manager To Do When the Time to Terminate Comes?

Posted By Cynthia B. Hanson, Thursday, October 8, 2015

Best practices can be just as important in the final stretches of a partnership as they are when development and trials are proceeding apace or the revenue stream is peaking. How to gracefully negotiate that last stretch before the parting handshake was the focus of “The Graceful Exit: Preserving Value and Relationship at the End of the Lifecycle” presented at the 2015 ASAP BioPharma Conference on Sept. 10 by Diana L. Brassard, CA-AM, of external partnerships at Basalta US Inc., Mark Coflin, CSAP, senior director of alliance management global business development & licensing, bioscience, at Baxalta US Inc., and Julia Gershkovich, head of US R&D alliance management at Sanofi.

 

Good preparation for terminations preserves companies’ reputations and secures future opportunities. “Preparation is critical,” said Gershkovich. “If a partner decided to terminate, the project team may not be already there. When you get to the termination point, all internal stakeholders need to be aware and agree on this point. There needs to be respect toward the partner and transparencya lot of times we are dealing with smaller companies, and it means a lot to them.”

 

“One termination that comes to mind was with a Japanese company that was well-prepared and respectful,” recalled Coflin. “We thought about how we were going to communicate with them and how to deliver the message, including whether we should be meeting with them face-to-face. It needs to be done in mutually respectful way, because there might be future business.”

 

The termination process often is very long and termination activity can take two years, observed Brassard. “There is a need internally to lock in and assure that you have resources, budgets assigned, and clarity with respect to senior leadership and with respect to obligations.”

 

Go through very defined, structured procedures, followed by putting together a table for when the transactions would go throughbefore the termination is completed, she added. “This is all very important for business development and legal procedures, and eventually for resource allocations to maintain the core team.”

 

When is it appropriate to wear more of a project management hat as an alliance manager during the termination process? “There were one or two projects where I played both roles,” said Brassard. “When things started getting more negative, and the data coming in was negative, there was a decision that the alliance manager was going to take more of a key role. The alliance management best practices were not complimentary to each other, so it was very helpful to have project management tools. A lot of what I was trying to do was maintain a respectful relationship.”

 

“I was fortunate in most of my cases,” added Gershkovich. “I had project managers working with me, and they were great. We had to deliver the messages, and in one case it was clear that it was mutually understandable because the data didn’t work out. But in another case, we had to go to district resolution to stop the program, and we were still able to continue the relationship and preserve the value.”

 

A smattering from their list of dos and don’ts:  

  • Let partners know as soon as possible.
  • Map out a communication plan.
  • Meet regularly.
  • Get together with legal stakeholders, and go through the legal provisions of the contract.
  • Be aware of cultural differences, sensitivities, and time zones.
  • Negotiate in a way where value is preserved; present it in a way that they can take it right away.
  • Intellectual property is importantbe prepared that all checkpoints are done.
  • Prior to a termination notice, communicate with your partnerthe process is so much easier with good communication if the program doesn’t work out.
  • Include public and investor announcements, but if a company may go bankrupt and/or the product may be taken out of the pipeline, minimize the announcement.
  • Craft the termination carefully, and keep in mind there may be ongoing studies.
  • Don’t assume your partner is going to be as organized and experienced as you are.
  • Don’t assume they have plans for receiving the asset that you have made.

Tags:  2015 ASAP BioPharma Conference  alliance management  Basalta US Inc.  Baxalta US Inc.  Best practices  communicate  Diana L. Brassard  Julia Gershkovich  Mark Coflin  partner  partnership  project management  Sanofi  stakeholders  terminations  transparency 

Share |
PermalinkComments (0)
 
For more information email us at info@strategic-alliances.org or call +1-781-562-1630